The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Open accessAbstract
Present review highlights various drug delivery systems used for delivery of pharmaceutical agents mainly antibiotics, antineoplastic agents, neuropeptides, and other therapeutic substances through the endothelial capillaries (BBB) for CNS therapeutics. In addition, the use of ultrasound in delivery of therapeutic agents/biomolecules such as proline rich peptides, prodrugs, radiopharmaceuticals, proteins, immunoglobulins, and chimeric peptides to the target sites in deep tissue locations inside tumor sites of brain has been explained. In addition, therapeutic applications of various types of nanoparticles such as chitosan based nanomers, dendrimers, carbon nanotubes, niosomes, beta cyclodextrin carriers, cholesterol mediated cationic solid lipid nanoparticles, colloidal drug carriers, liposomes, and micelles have been discussed with their recent advancements. Emphasis has been given on the need of physiological and therapeutic optimization of existing drug delivery methods and their carriers to deliver therapeutic amount of drug into the brain for treatment of various neurological diseases and disorders. Further, strong recommendations are being made to develop nanosized drug carriers/vehicles and noninvasive therapeutic alternatives of conventional methods for better therapeutics of CNS related diseases. Hence, there is an urgent need to design nontoxic biocompatible drugs and develop noninvasive delivery methods to check posttreatment clinical fatalities in neuropatients which occur due to existing highly toxic invasive drugs and treatment methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–239 of 239
Strategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling
Wager, T. T., Liras, J. L., Mente, S., & Trapa, P. E. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677028 · Cited by 38
Ningaraj, N. S., Rao, M. K., & Black, K. L. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.5.878815 · Cited by 37
Kuo, Y., & Wang, C. (2013) · Biotechnology Progress · doi:10.1002/btpr.1834 · Cited by 37
Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes
Paoli, E. E., Ingham, E. S., Zhang, H., Mahakian, L. M., Fite, B. Z., Gagnon, M.-H., Tam, S. M., Kheirolomoom, A., Cardiff, R. D., & Ferrara, K. W. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.005 · Cited by 36
Li, K., Han, H., Zhu, K., Lee, K., Liu, B., Zhou, F., Fu, Y., & He, Q. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.071 · Cited by 36
What evidence supports use of erythropoietin as a novel neurotherapeutic?
Brines, M. L. (2002) · PubMed · Cited by 36
Carbopol-Based Gels for Nasal Delivery of Progesterone
Rathnam, G., Narayanan, N., & Ilavarasan, R. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9144-7 · Cited by 35
Weyerbrock, A., Walbridge, S., Saavedra, J. E., Keefer, L. K., & Oldfield, E. H. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq161 · Cited by 35
Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury
Wei, G. (2007) · Frontiers in bioscience · doi:10.2741/2443 · Cited by 35
Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Kaira, K., Murakami, H., Endo, M., Ohde, Y., Naito, T., Kondo, H., Nakajima, T., Yamamoto, N., & Takahashi, T. (2013) · PubMed · Cited by 34
Guillemyn, K., Kleczkowska, P., Novoa, A., Vandormael, B., den Eynde, I. V., Kossoń, P., Asim, M. F., Schiller, P. W., Spetea, M., Lipkowski, A. W., et al. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-4 · Cited by 34
Landau, A. J., Eberhardt, R. T., & Frishman, W. H. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90391-3 · Cited by 33
Delivery of a Peptide Radiopharmaceutical to Brain with an IgG-Avidin Fusion Protein
Zhou, Q.-H., Lu, J. Z., Hui, E. K., Boado, R. J., & Pardridge, W. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200174x · Cited by 33
Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33
Kuo, T., Wang, D., Chiu, Y.-C., Yeh, Y., Chen, W.-T., Chen, C.-H., Chen, C.-H., Chen, C., Chen, C., Chang, H., et al. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.11.050 · Cited by 32
Cyclen-Based Cationic Lipids for Highly Efficient Gene Delivery towards Tumor Cells
Huang, Q., Zhong, G., Zhang, Y., Ren, J., Fu, Y., Zhang, J., Zhu, W., & Yu, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023134 · Cited by 32
Polymeric micelles as a drug carrier for tumor targeting
Ayre, A. P., Kadam, V., Dand, N., & Patel, P. (2013) · Chronicles of young scientists · doi:10.4103/2229-5186.115544 · Cited by 32
Breast cancer resistance protein (Bcrp) and the testis—an unexpected turn of events
Qian, X., Cheng, C. Y., Mruk, D. D., & Cheng, C. Y. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.24 · Cited by 30
Hui, E. K., Boado, R. J., & Pardridge, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900103n · Cited by 28
Steinert, S., Lee, E., Tresset, G., Zhang, D., Hortsch, R., Wetzel, R., Hebbar, S., Sundaram, J. R., Kesavapany, S., Boschke, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002933 · Cited by 28
Sarwa, K. K., Suresh, P. K., Rudrapal, M., & Verma, V. K. (2014) · Current Drug Delivery · doi:10.2174/1567201811666140115113127 · Cited by 28
Tang, J., Fu, H., Kuang, Q., Zhang, L., Zhang, Q., Liu, Y., Ran, R., Gao, H., Zhang, Z., & He, Q. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.875029 · Cited by 26
Hathout, R. M. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.813544 · Cited by 26
Crossing Barriers From blood-to-brain and academia-to-industry
Gaillard, P. J. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.43 · Cited by 25
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging
Ortiz-Arzate, Z., Santos‐Cuevas, C., Ocampo‐García, B., Ferro‐Flores, G., Garcı́a-Becerra, R., Estrada, G., Gómez-Argumosa, E., & Izquierdo-Sánchez, V. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000065 · Cited by 24
Marcondes, M. C. G., Flynn, C. T., Huitrón‐Reséndiz, S., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4af0 · Cited by 23
Nanoneurotoxicity to Nanoneuroprotection Using Biological and Computational Approaches
IQBAL, A., Ahmad, I., Khalid, M. H., Nawaz, M. S., Gan, S. H., & Kamal, M. A. (2013) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2013.829706 · Cited by 23
Asthana, S., Gupta, P. K., Chaurasia, M., Dube, A., & Chourasia, M. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.838216 · Cited by 22
Tsujiuchi, T., Natsume, A., Motomura, K., Kondo, G., Ranjit, M., Hachisu, R., Sugimura, I., Tomita, S., Takehara, I., Woolley, M., et al. (2014) · Europe PMC (PubMed Central) · Cited by 20
Zhang, L., Cao, D.-Y., Wang, J., Xiang, B., Jn, D., Fang, Y., & Xue, G.-Q. (2013) · PubMed · Cited by 18
Saffari, M., Shirazi, F. H., Oghabian, M. A., & Moghimi, H. R. (2013) · PubMed Central · Cited by 18
Targeted liposomal drug delivery systems for the treatment of B cell malignancies
Mittal, N. K., Bhattacharjee, H., Mandal, B., Balabathula, P., Thoma, L. A., & Wood, G. C. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.878942 · Cited by 16
Schaddelee, M. P., Voorwinden, H. L., Groenendaal, D., Hersey, A., IJzerman, A. P., Danhof, M., & de Boer, A. G. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.08.003 · Cited by 16
Short interfering RNA and the central nervous system: development of nonviral delivery systems
Nishina, K., Mizusawa, H., & Yokota, T. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.748746 · Cited by 8
Surface masking shapes the traffic of the neuropeptide Y Y2 receptor
Parker, M. S., Sah, R., & Parker, S. L. (2012) · Peptides · doi:10.1016/j.peptides.2012.06.008 · Cited by 7
Ji, B., Cen, J., Liu, L., & He, L. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.10.005 · Cited by 7
Yamada, T. (2004) · PubMed Central · Cited by 7
Albumin Acts Like Transforming Growth Factor β1 in Microbubble-Based Drug Delivery
Chuang, Y.-H., Wang, Y.-H., Chang, T.-K., Lin, C., & Li, P. (2014) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.10.022 · Cited by 6
Lu, X., Zhao, L., Xue, T., & Zhang, H. (2013) · PubMed · Cited by 4
Cited by
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537
A Review on Central Nervous System Effects of Gastrodin
Liu, Y., Gao, J., Peng, M., Meng, H., Ma, H., Cai, P., Xu, Y., Zhao, Q., & Si, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00024 · Cited by 387
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Metadata
- Authors
- Upadhyay, R. K.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-37
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2164322384
- Cited by
- 528
- References
- 239
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.